Citations

Showing 10 of 108104 citations.

P884Can biomarkers be used to predict cardiopulmonary exercise test performance in patients with chronic heart failure?
Jones, Aaron D. , Coles, Adrian , McNulty, Sid, Redfield, Margaret M. , Network, Heart Failure, Fudim, Marat , Kelly, Joseph , Lewis, Gregory D. , Hernandez, Adrian F. , Felker, G. Michael , Network, Heart Failure

Mayo Clinic

European Heart Journal | August 29, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy564.p884 Get It

P4536Right atrial mechanics predict outcome in patients diagnosed with pre-capillary pulmonary hypertension
Tunhasiriwet, Anusith, Krittanawong, Chayakrit , Tunthong, Ramaimon, Bailey, Kent R. , Pislaru, Cristina , Kane, G, Pislaru, Cristina

Mayo Clinic

European Heart Journal | August 29, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p4536 Get It

Short segment sensory nerve stimulation in suspected ulnar neuropathy at the elbow: A pilot study
Campo, Rocio Vazquez Do , Dimberg, Elliot L., Rubin, Devon I., Vazquez do Campo, Rocio, Dimberg, Elliot, Rubin, Devon, Vazquez Do Campo, Rocio

Mayo Clinic

Muscle & Nerve | August 29, 2018 | Volume: 59 | Issue: 1 | Pages: 125-129

10.1002/mus.26326 | PMID 30151865 Get It

ABSTRACTIntroduction: Routine ulnar nerve conduction studies may be normal in very mild ulnar neuropathies at the elbow (UNE). Short segment ulnar sensory stimulation across the elbow may detect mild abnormalities in these cases. Methods: Short segment ulnar sensory nerve stimulation was performed in 20 controls and 15 patients with clinically suspected mild UNE. Greatest peak latency shift and amplitude drop between 2 adjacent stimulation sites were calculated. Results: The upper limit of normal for peak latency shift and amplitude reduction between sites was 0.7 ms and 15%, respectively. Abnormal latency shift was detected in 12 of 15 patients and focal sensory conduction block in 6 of 15 patients. In 5 of 7 patients in whom all other studies were normal, sensory inching was abnormal. Discussion: Ulnar sensory short segment stimulation may provide diagnostic confirmation and localization of the site of nerve compression in mild UNE, and may improve UNE detection when all other studies are normal. Muscle Nerve 59:125–129, 2019
Evaluation of genotoxicity related to oral methylene blue chromoendoscopy
Repici, Alessandro , Ciscato, Camilla , Wallace, Michael B. , Anderloni, Andrea , Carrara, Silvia , Leo, Milena Di , Hassan, Cesare , Hassan, Cesare , Wallace, Michael B , Sharma, Prateek

Mayo Clinic

Endoscopy | August 29, 2018 | Volume: 50 | Issue: 10 | Pages: 1027-1032

10.1055/a-0630-1004 | PMID 29906809 Get It

Abstract Background An oral formulation of methylene blue with colonic delivery (MB-MMX) has been developed to increase detection of colorectal polys during colonoscopy. Traditionally, there have been safety concerns regarding DNA damage when methylene blue is exposed to white light. The aim of this study was to evaluate DNA damage in colonic mucosa after MB-MMX chromoendoscopy. Methods This was an open-label phase II safety study to assess for genotoxicity on colorectal biopsies of patients undergoing two sequential colonoscopies before and after an oral dose of 200 mg MB-MMX added to their bowel prep. Analysis of a biomarker of double-stranded DNA breaks, γH2AX, was performed on biopsy specimens. Results Ten patients were included in the study. The mean expression of γH2AX ± 95 % confidence intervals of the 50 biopsies before and after MB-MMX administration were 0.58 ± 0.08 and 0.62 ± 0.09, respectively (P = 0.24). None of the analyzed samples showed excess positive γH2AX expression, confirming the absence of DNA damage on biopsies after methylene blue exposure. No deaths or serious adverse events occurred. Conclusions An oral dose of 200 mg of MB-MMX did not result in any detectable DNA damage.
P3633Different temporal patterns of left ventricular post-infarction remodelling: characteristics and clinical outcome
Bijl, Pieter van der , Abou, Rachid , Goedemans, Laurien, Holmes, David R. , Gersh, Bernard J. , Marsan, Nina Ajmone , Delgado, Victoria , Bax, Jeroen J.

Mayo Clinic

European Heart Journal | August 29, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p3633 Get It

P902Patient-centered communication and outcomes in heart failure
Fabbri, Matteo, Rutten, Lila Finney, Manemann, Sheila M., Boyd, Cynthia M. , Weston, Susan A., Yost, Kathleen J. , Killian, Jill M. , Roger, Véronique L. , Wolff, Jennifer L. , Chamberlain, Alanna M. , Griffin, Joan M.

Mayo Clinic

European Heart Journal | August 29, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy564.p902 Get It

P2895Evaluation of the effect of oral anticoagulants on all-cause mortality within 3 months of the diagnosis of atrial fibrillation: results from the GARFIELD-AF prospective registry
Camm, A. John , Bassand, Jean‐Pierre , Fitzmaurice, David , Goldhaber, Samuel Z. , Goto, Shinya , Haas, Sylvia , Misselwitz, Frank , Pieper, Karen S. , Turpie, Alexander G. G. , Verheugt, Freek W.A., Kakkar, A.K. , Investigators, GARFIELD-AF, Fox, Keith A.A. , Berchuck, Samuel I. , Gersh, Bernard J. , Investigators, GARFIELD-AF

Mayo Clinic

European Heart Journal | August 29, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy565.p2895 Get It

BERNARD-SOULIER SYNDROME: WHOLE BLOOD DIAGNOSTIC ASSAYS OF PLATELETS
Nichols, William L., Kaese, S E, Gastineau, D.A., Otteman, L A, Bowie, Ejw, Gastineau, D A

Mayo Clinic

Thrombosis and Haemostasis | August 29, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1644561 Get It

Diagnosis of Bernard-Soulier syndrome (BSS) is complicated by the difficulty of separating the giant platelets from other blood cells to pursue analyses of platelet function and structure. We report on the utility of three whole blood assay techniques for diagnosis of a patient with BSS. To our knowledge, these three techniques have not been simultaneously applied or compared for efficacy in laboratory diagnosis of BSS. (1) Whole blood platelet aggregation responses, studied with an electrical impedence aggregometer, were equivalent to those more laboriously obtained using platelet-rich plasma prepared by unit gravity sedimentation, studied with an optical light transmittance aggregometer. Platelet aggregation responses were normal with ADP or collagen stimulation, and absent with Ristocetin or bovine plasma stimulation. (2) Whole blood radioimmunoassay of platelet glycoprotein (GP) expression was performed using iodinated murine monoclonal antibodies HP1-1D (anti-GP IIb/IIIa) and 6D1 (anti-GPlb, kindly supplied by Dr. Barry Coller, Stony Brook, NY). After incubation with citrated whole blood, centrifugation was used to separate cell-bound antibody which was quantitated with a gamma counter. The patient’s whole blood had a normal level of cell-bound GP Ilb/IIIa, but a markedly reduced level of cell-bound GP lb (5% of normal mean; n = 20). (3) Whole blood smear immunocytochemical staining with the monoclonals (indirect immuno-alkaline phosphatase technique), and qualitative analysis by light microscopy, revealed a marked reduction of GP lb expression by the patient’s giant platelets, whereas GP Ilb/IIIa expression was normal. This latter technique might be especially valuable as a screening technique when the patient is not directly available for laboratory study. Together with the patient’s life-long history of thrombocytopenia and moderate bleeding diathesis, and other laboratory observations including markedly prolonged bleeding times and reduced whole blood prothrombin consumption, these data established diagnosis of BSS. We conclude that these three relatively simple assays of platelets in whole blood should be of particular value in the laboratory differential diagnosis of patients with congenital thrombocytopenias and giant platelet syndromes.
PLATELETS, ENDOTHELIUM AND VASOSPASM
Vanhoutte, Paul M.

Mayo Clinic

Thrombosis and Haemostasis | August 29, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1643722 Get It

The endothelium can secrete both relaxing and contracting substances. One of the most powerful stimuli to the release of the former are thrombin and aggregating platelets. This contributes to the protective role of the endothelium against inappropriate intraluminal platelet aggregation and coagulation in blood vessels with an intact intima. Thrombin-induced, endothelium-dependent relaxations have been obtained in isolated arteries of different species, including humans. Endothelium-dependent relaxations can be evoked by autologous platelets in isolated blood vessels of the dog, pig and rat; they can be obtained in canine coronary arteries with human platelets. The major platelet-products involved in these endothelium-dependent relaxations are 5-hydroxytryptamine (serotonin) and the adenine nucleotides. Although platelet-activating factor (PAF) can evoke endothelium-dependent relaxation it only does so at concentrations much higher than those occurring under physiological conditions; since the relaxations are not prevented by PAF-antagonists, they are non-specific in nature.The receptor mediating the endothelium-dependent relaxations to serotonin released from the aggregating platelets can be subtyped as a S1~(5HT1) serotonergic receptor;those mediating the response to the adenine nucleotides as P2y-purinergic receptors. In the absence of the endothelium aggregating platelets cause contractions of vascular smooth muscle; these are mediated by a mixture of S1-like and S2~serotoner-gic receptors in coronary arteriesof the dog, and by S2-serotonergic receptors in those of the pig. Thus, in the porcine coronary artery, the S2-serotonergic antagonist ketanserin markedly enhances the platelet-induced endothelium-dependent relaxation. After previous (four weeks) injury, the regenerated endothelium of the porcine coronary artery loses the ability to respond to serotonin,and is unable to prevent the constrictionsevoked by aggregating platelets. The endothelium-dependent relaxations of porcine coronary arteries evoked by aggregating platelets are potentiated by chronic treatmentof the donor animals with cod liver oil. These studies emphasize the protective roleof the endothelial cells against the vasoconstriction (vasospasm) induced by aggregating platelets. This role is depressed after previous injury, and can be facilitatedby dietary adj ustments.
HEMOSTATIC EVALUATION OF PATIENTS UNDERGOING LIVER TRANSPLANTATION
Rettke, Steven R., Owen, C.A., Bowie, Ejw, Cole, T L, Wiesner, R H, Krom, Ruud A. F., Jensen, Christine C. , Owen, C A

Mayo Clinic

Thrombosis and Haemostasis | August 29, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/s-0038-1643070 Get It

Significant hemostatic abnormalities can occur during orthotopic liver transplantation (OLT). This study addressed three goals: 1)evaluation of the hemostatic mechanism at each stage of the OLT; 2) the relationship of the coagulation process with the thrombelastograph (TEG); and 3) comparison of results in patients requiring retransplantation or who died, with the overall pattern. To evaluate hemostasis during 50 consecutive OLTs, a detailed coagulation and TEG study was done. The surgical procedure was divided into the following stages: Stage I--induction of anesthesia to occlusion of blood flow to the patient’ s diseased liver; Stage II—occlusion of blood flow to the patient’ s diseased liver to reperfusion of the patient’ s new liver; and Stage III—reperfusion of the new liver until skin closure. 28 ml of arterial blood were sampled at the beginning and end of each stage and up to five days posttransplantation for the following: platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen, prothrombin, factors V, VII, IX, and X, plasminogen, antiplasmin, antithrombin III (functional and immunologic), fibrinolytic split products, and TEG. The patient’ s core temperature and amount of blood products transfused were obtained intraoperatively during each of the six data times. The ischemia time of the donor liver was recorded. Significant hemostatic abnormalities developed during each of the 50 OLTs, especially during reperfusion of the donor liver. In some instances, this was corrected within one hour, but platelet counts continued to fall, and a number of coagulation factors rebounded only partially. The TEG values correlated with laboratory data and blood loss, but the correlations were not strong. The patient’ s requirement for red cells varied with the operative drop in temperature; however, the donor liver ischemia time and length of Stage II made no significant difference. It is concluded that 1) significant deterioration of coagulation factors occurs during OLT, 2) the TEG is an effective screening test that affords prompt information, 3) aggressive measures should be taken to maintain the patient’ s body temperature at 37°C, 4) patient outcome was not predicted by intraoperative hemostatic evaluation.